Werbung
Werbung
INAB
IN8bio, Inc. Common Stock
2.40
USDGesponsert
-0.10
-3.80%
08. Jan., 15:50 UTC -5
Geschlossen
Nach-Markt
2.38
-0.03
-1.21%
INAB Ergebnisberichte
Positives Überraschungsverhältnis
INAB übertreffen die 10 der letzten 17Schätzungen.
59%
Nächster Bericht
Datum des nächsten Berichts
02. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.69
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/-18.82%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-42.50%
IN8bio, Inc. Common Stock earnings per share and revenue
On 06. Nov. 2025, INAB reported earnings of -0.85 USD per share (EPS) for Q3 25, beating the estimate of -1.25 USD, resulting in a 32.25% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.63% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.69 USD, with revenue projected to reach -- USD, implying an decrease of -18.82% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were IN8bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, IN8bio, Inc. Common Stock reported EPS of -$0.85, beating estimates by 32.25%, and revenue of $0.00, 0% as expectations.
How did the market react to IN8bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -6.63%, changed from $1.66 before the earnings release to $1.55 the day after.
When is IN8bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for 02. März 2026.
What are the forecasts for IN8bio, Inc. Common Stock's next earnings report?
Based on 4
analysts, IN8bio, Inc. Common Stock is expected to report EPS of -$0.69 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung